Lars Møller Pedersen

Author

Also Known As

CAVALLI, MARZIA, L Elkjær Pedersen, L M PEDERSEN, L M Pedersen, L Møller Pedersen, L Pedersen, L. M. PEDERSEN, L. M. Pedersen, L. Møller Pedersen, L. Pedersen

192

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

Herlev Hospital Odense University Hospital University of Copenhagen Roskilde Sygehus Rigshospitalet

About

Lars Møller Pedersen is an author at Herlev Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	2.5K
2	Health Sciences	4	4	163
3	Nursing	1	1	131
4	Public Health	1	1	30
5	Anesthesia	1	1	29

Lars Møller Pedersen

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Gilles Salles, John F. Seymour, Fritz Offner, The Lancet Lymphoid NeoplasiaOncologyPhase 3Follicular LymphomaPathology	2010	1.1K
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma Martin Hutchings, Annika Loft, Mads Hansen, Blood	2005	715
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Tina Green, Ken H. Young, Carlo Visco, Journal of Clinical Oncology	2012	677
Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study Bertrand Coiffier, Stéphane Leprêtre, Lars Møller Pedersen, Blood	2007	383
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study Emmanuel Bachy, John F. Seymour, Pierre Feugier, Journal of Clinical Oncology	2019	266
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial Anton Hagenbeek, Ole Gadeberg, Peter Johnson, Blood	2008	263
Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial Anne Wikkelsø, Hellen McKinnon Edwards, Arash Afshari, British Journal of Anaesthesia Pre-emptive TreatmentFibrinogen ConcentratePostpartum HemorrhagePostpartum HaemorrhageGynecology	2015	255
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Martin Hutchings, Annika Loft, Mads Hansen, PubMed	2006	237
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study Anna Abrahamsson, Alexandra Albertsson‐Lindblad, Peter de Nully Brown, Blood	2014	133
Symptomatology of cancer patients in palliative care Annette S Strömgren, M. Groenvold, Lars Møller Pedersen European Journal of Cancer NursingPalliative CareMedicineSymptomatic TreatmentDiagnosis	2002	131

Page 1